Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cipla
Accenture
Express Scripts
Baxter
Boehringer Ingelheim

Generated: March 25, 2019

DrugPatentWatch Database Preview

Butabarbital sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for butabarbital sodium and what is the scope of butabarbital sodium patent protection?

Butabarbital sodium is the generic ingredient in ten branded drugs marketed by Medpointe Pharm Hlc, Alpharma Us Pharms, Wockhardt, Lannett, Meda Pharms, Halsey, Bundy, Sandoz, Solvay, Teva, Watson Labs, Whiteworth Town Plsn, Mylan Speciality Lp, Hikma Pharms, Ivax Sub Teva Pharms, and Marshall Pharma, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for butabarbital sodium. One supplier is listed for this compound.

Synonyms for butabarbital sodium
125-40-6
143-81-7
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-, monosodium salt
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(2-methylpropyl)-, sodium salt
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(2-methylpropyl)-, sodium salt (9CI)
2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-
2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-, monosodium salt
5-(butan-2-yl)-5-ethyl-1,3-diazinane-2,4,6-trione
5-(butan-2-yl)-5-ethyl-4,6-dihydroxy-2,5-dihydropyrimidin-2-one
5-(butan-2-yl)-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione
5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-(1-methylpropyl)barbiturate
5-Ethyl-5-(1-methylpropyl)barbituric acid
5-Ethyl-5-(1-methylpropyl)barbituric acid sodium salt
5-Ethyl-5-(1-methylpropyl)barbituric acid, sodium salt
5-ethyl-5-(1-methylpropyl)pyrimidine-2,4,6(1H,3H,5H)-trione
5-Ethyl-5-isobutylbarbituric acid
5-ethyl-5-sec-butyl-barbituric acid
5-ethyl-5-sec-butyl-hexahydropyrimidine-2,4,6-trione
5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione #
5-SEC-BUTYL-5-ETHYL-BARBITURIC ACID
5-SEC-BUTYL-5-ETHYL-BARBITURIC ACID, NA SALT
5-sec-Butyl-5-ethylbarbituric acid
5-sec-Butyl-5-ethylbarbituric acid sodium salt
5-sec-Butyl-5-ethylbarbituric acid, sodium salt
5-sec-Butyl-5-ethylmalonyl urea
5-sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
97164-73-3
AC-16078
AC1L1DRT
AC1Q1VYO
AKOS015962208
AN-22964
API0004766
Asturidon
Barbitab
Barbituric acid, 5-ethyl-5-isobutyl-
Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt
Barbituric acid, 5-sec-butyl-5-ethyl-
Barbituric acid, 5-sec-butyl-5-ethyl-, sodium salt
BRN 0199127
BRN 0199734
Bubartal
Bubartal TT
Butabarb
Butabarb (TN)
butabarbital
Butabarbital (USP)
Butabarbital (VAN)
Butabarbital [USAN]
Butabarbital [USP]
Butabarbital |||5-sec-Butyl-5-ethylbarbituric acid
Butabarbital sodium (USP)
Butabarbital sodium [USAN]
Butabarbital sodium [USP]
Butabarbital solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Butabarbitone
Butabarbitone sodium
Butabarpal sodium
Butak
Butalan
Butasaron
Butased
Butatab
Butatal
Butatal sodium
Butazem
Butibel
Buticaps
Butisol
Butisol sodium
Butrate
C07827
C10H15N2NaO3
Cambrised
Carrbutabarb
CHEBI:3228
CHEBI:3229
CHEMBL1200982
CHEMBL449
Ciprial
component of Butibel
CS-7224
D00699
D03180
DB00237
DTXSID2022709
EINECS 204-738-6
EINECS 205-611-8
Expansatol
FT-0663911
GTPL7137
HSDB 3018
HY-U00167
Insolat
Intasedol
Loubarb
LS-23930
LS-23946
LS-24330
LS-24334
Mebutal
Medarsed
Nerauan
Neravan
Nilox
Noctinal
NSC 11778
NSC 27517
NSC-11778
NSC-27517
NSC11778
NSC27517
Paxital (VAN)
Prelital
Pyridium plus (Salt/Mix)
Quiebar
Sarisol
Sarisol No. 1
SARISOL NO. 2
SCHEMBL122121
SCHEMBL79254
sec-Butobarbitone
Secbubarbital
Secbubarbital sodium
Secbutabarbital
Secbutabarbital (BAN)
Secbutabarbital [INN:BAN]
Secbutabarbital [INN]
Secbutabarbital sodique
Secbutabarbital sodium
Secbutabarbital sodium (INN)
Secbutabarbitale
Secbutabarbitale [DCIT]
Secbutabarbitalum
Secbutabarbitalum [INN-Latin]
Secbutobarbital
Secbutobarbitone
Secbutobarbitone sodium
Seda-Bute
Sodium 5-(sec-butyl)-5-ethylbarbiturate
Sodium 5-ethyl-5-(1-methylpropyl)barbiturate
Sodium 5-ethyl-5-sec-butylbarbiturate
Sodium 5-sec-butyl-5-ethylbarbiturate
Sodium butabarbital
Sodium butobarbitone
Unicelles
WLN: T6VMVMV FHJ FY2 & 1 F2
ZRIHAIZYIMGOAB-UHFFFAOYSA-N

US Patents and Regulatory Information for butabarbital sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Halsey SARISOL butabarbital sodium ELIXIR;ORAL 084723-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Speciality Lp BUTISOL SODIUM butabarbital sodium TABLET;ORAL 000793-004 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lannett SODIUM BUTABARBITAL butabarbital sodium TABLET;ORAL 085849-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Marshall Pharma SODIUM BUTABARBITAL butabarbital sodium TABLET;ORAL 083858-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 088631-001 May 1, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Marshall Pharma SODIUM BUTABARBITAL butabarbital sodium TABLET;ORAL 083524-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wockhardt BUTABARBITAL SODIUM butabarbital sodium ELIXIR;ORAL 085383-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Medtronic
Queensland Health
Citi
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.